wegovy hims - Search News

News

Novo, Hims & Hers engage in war of words

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's goal to lead the weight loss market.

CBS News on MSN · 4d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Reuters on MSN · 4d

Novo, Hims & Hers engage in war of words after Wegovy deal falls apart

Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending shares of the U.S. telehealth company plunging more than 30%. The companies,

1hon MSN

Hims & Hers' ugly split with Wegovy maker weighs on the telehealth company's future

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

12h

Without GLP-1 Hims & Hers Is A $20s Per Share Stock -- Sell Call

Novo Nordisk ends partnership with Hims & Hers, causing a 35% plunge. With no near-term catalysts, learn why investors must ...

Daily Voice on MSN4d

Plainsboro-Based Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug Sales

Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...

Newsday3d

Novo Nordisk pulls Wegovy from Hims & Hers. LI experts weigh in.

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy used for weight loss since late April in order to transition patients off compounded drugs, according to the news release.

Hims & Hers Sued Over Wegovy Maker’s Exit, Record Stock Selloff

Hims & Hers Health Inc. investors have sued the telehealth provider days after Novo Nordisk A/S announced it was ending the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results